This protocol is written following the Preferred Reporting Items for Systemic Review and Meta Analysis Protocol (PRISMA-P) statement. [19] And this protocol is registered in PROSPERO (CRD42019124737). Ethical approval is not needed because this research only involves published data. 2.1. Eligibility criteria 2.1.1. Type of study. Only RCTs will be included in this study. study. Patients with other concomitant ocular disease will be excluded. Studies enrolled <10 patients will also be excluded. 